Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRGEMAX: Sequential Treatment in Metastatic Pancreatic Cancer
NCT02827201Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, fluorouracil, folinic acid, sponsored by Fédération Francophone de Cancérologie Digestive. Started Nov 2015; status: completed.
02
Drugs
irinotecanfluorouracilfolinic acid
Beyond the preview
Go deeper on NCT02827201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02827201.